Recent Updates
Recently added Catalysts
REGN

Regeneron Announces Results of Phase III Obesity Study

Tuesday, April 1, 2003 1 min read
Key Takeaway: Regeneron Announces Results of Phase III Obesity Study

Full Press Release Details

Regeneron Announces Results of Phase III Obesity Study.
Tags: REGN Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Apr 1, 2003